BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 9008403)

  • 1. The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus.
    Gorus FK
    Verh K Acad Geneeskd Belg; 1996; 58(5):539-86. PubMed ID: 9008403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of type 1 diabetes at onset in children: results from the French Incidence Study.
    Levy-Marchal C; Czernichow P
    Diabete Metab; 1993; 19(3):296-303. PubMed ID: 8405620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening, prediction and prevention of type 1 diabetes. Role of the Belgian Diabetes Registry].
    Dorchy H
    Rev Med Brux; 1999 Feb; 20(1):15-20. PubMed ID: 10091531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventative biology of type 1 diabetes: implications for clinical preventative studies].
    Gorus FK; Weets I; Decochez K; van der Auwera BJ
    Verh K Acad Geneeskd Belg; 2003; 65(4):203-29; discussion 229-31. PubMed ID: 14534938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family members.
    Thivolet C; Nicolino M; Monbeig S; Estour B; Halimi S; Robert M; Orgiazzi J; Chatelain P;
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):279-85. PubMed ID: 12442065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
    Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive genetic screening for type-1 diabetes in the Hungarian population].
    Hermann R; Soltész G
    Orv Hetil; 2004 Feb; 145(7):337-42. PubMed ID: 15049049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
    Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
    J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
    Hermann R; Gombos Z; Gyürüs E; Soltész G
    Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
    Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
    Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In new-onset insulin-dependent diabetic patients the presence of anti-thyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLA DQA1*0301-DQB1*0302. Belgian Diabetes Registry.
    Abrams P; De Leeuw I; Vertommen J
    Diabet Med; 1996 May; 13(5):415-9. PubMed ID: 8737022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
    Williams AJ; Bingley PJ; Moore WP; Gale EA;
    Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
    Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
    Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
    Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
    Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
    Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
    Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology, prediction and prevention of type 1 diabetes: not one fiction in Belgium].
    Gorus FK
    Verh K Acad Geneeskd Belg; 2008; 70(1):5-24. PubMed ID: 18512356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility.
    Siljander H; Härkönen T; Hermann R; Simell S; Hekkala A; Salonsaari RT; Simell T; Simell O; Ilonen J; Veijola R; Knip M
    Diabetes Metab Res Rev; 2009 Oct; 25(7):615-22. PubMed ID: 19637309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetes.
    Truyen I; De Grijse J; Weets I; Kaufman L; Pipeleers L; Nanos N; Decochez K; Hilbrands R; Kaufman JM; Keymeulen B; Mathieu C; Van Gaal L; Pipeleers DG; Gorus FK;
    Clin Exp Immunol; 2007 Aug; 149(2):243-50. PubMed ID: 17521324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.